News

German pharmaceutical firm BioNTech, one of the first companies worldwide to develop an effective coronavirus vaccine, is looking to acquire its domestic rival CureVac, the firm said on Thursday.
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in the ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the first dose in the first-in-human clinical trial to ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today ...
PR Newswire CHICAGO, May 23, 2025 CHICAGO Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and r ...
Lulu VanZandt Senior manager, brand, public relations and social media [email protected] M: +1 (508) 782-9484 SCIEX, a global leader in life science analytical technologies and operating company ...
Model post-training and inference will run on AI infrastructure in Europe from NVIDIA Cloud Partners ( NCPs) participating in ...
Coca-Cola's vitaminwater has taken a different approach with its rebrand. It's ditching the previous slightly pharmaceutical-looking identity in favour of bolder branding that aims to be fun rather ...
MacroGenics (the Company) is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of ...
Corbus Pharmaceuticals Holdings Inc. closed 85.74% short of its 52-week high of $61.90, which the company reached on July ...
ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced ...